Viewing Study NCT00675857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-01-07 @ 9:23 PM
Study NCT ID: NCT00675857
Status: COMPLETED
Last Update Posted: 2010-08-24
First Post: 2008-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Sponsor: Bellus Health Inc. - a GSK company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
None Metabolic Syndrome X View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type II diabetes View
None Metabolic syndrome View